Featured Research

from universities, journals, and other organizations

Study finds association between blood biomarker and risk of death

Date:
September 6, 2011
Source:
JAMA and Archives Journals
Summary:
In an analysis of data from two separate study groups, elderly men and women who had higher levels of the protein biomarker cathepsin S in their blood had an increased risk of death, according to a new study. This biomarker might have a relationship with the development of cardiovascular disease and cancer.

In an analysis of data from two separate study groups, elderly men and women who had higher levels of the protein biomarker cathepsin S in their blood had an increased risk of death, according to a study in JAMA. This biomarker might have a relationship with the development of cardiovascular disease and cancer.

Related Articles


The study was published early online to coincide with its presentation at the European Society of Cardiology Congress.

Cathepsin S is a cysteine protease (a type of enzyme) involved in intracellular and extracellular proteolysis (division of proteins by cellular enzymes). Higher circulating levels of cathepsin S have been shown to be associated with increased inflammatory activity. "Experimental studies suggest that cathepsin S activity is involved in the development of cardiovascular disease via promotion of atherosclerotic plaques and destabilization of advanced plaques. Moreover, cathepsin S activity has been implicated in the development of cancer via stimulation of cancer cell migration and tumor angiogenesis," according to background information in the article. Based on these previous reports, the authors hypothesized that circulating levels of cathepsin S would be a marker for an increased mortality risk. There has been a lack of prospective data regarding this potential association.

Elisabeth Jobs, M.Sc., of Uppsala University, Uppsala, Sweden, and colleagues investigated the association between serum levels of cathepsin S and the risk of mortality in a community-based sample of elderly men and women. The researchers used data from two independent community-based cohorts, the Uppsala Longitudinal Study of Adult Men (ULSAM; n = 1,009; average age: 71 years; baseline period: 1991-1995; median [midpoint] follow-up: 12.6 years; end of follow-up: 2006) and the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS; n = 987; 50 percent women; average age: 70 years; baseline period: 2001-2004; median follow-up: 7.9 years; end of follow-up: 2010). Serum samples were used to measure cathepsin S.

In the ULSAM group, 413 participants died during follow-up. There were a total of 131 deaths due to cardiovascular disease and 148 deaths due to cancer. During follow-up with the PIVUS cohort, 100 participants died. The researchers found that in multivariable models adjusted for age, systolic blood pressure, diabetes, smoking status, body mass index, total cholesterol, high-density lipoprotein cholesterol, antihypertensive treatment, lipid-lowering treatment, and history of cardiovascular disease, higher serum cathepsin S was associated with an increased risk for death.

In the PIVUS cohort, participants with the highest levels of serum cathepsin S had about double (200 percent) the risk of death compared to participants with the lowest levels. The authors also found that in the ULSAM cohort, participants with the highest levels of the biomarker had an approximately 1.6 times (60 percent) increased risk for cardiovascular mortality, and an increased risk for death from cancer.

"Our community-based data confirm and extend previous experimental research that suggest that cathepsin S activity is involved in the pathological processes leading to cardiovascular disease, cancer, and death," the researchers write.

"Given its putative role in atherogenesis and tumorigenesis, cathepsin S has been put forward as a possible target of pharmaceutical intervention and the development of selective cathepsin S inhibitors is ongoing. Some of these inhibitors are being evaluated in various phases of clinical trials. If these drugs are found to be effective, tools for identification of target groups and monitoring of treatment need to be developed. Our study suggests that it is possible to assess serum levels of cathepsin S in large populations. Future intervention trials are needed to evaluate whether cathepsin S inhibition is a safe and effective pharmacological target for these diseases."

The authors add that "further research is needed to determine the utility of cathepsin S measurements in clinical settings."


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. E. Jobs, E. Ingelsson, U. Riserus, E. Nerpin, M. Jobs, J. Sundstrom, S. Basu, A. Larsson, L. Lind, J. Arnlov. Association Between Serum Cathepsin S and Mortality in Older Adults. JAMA: The Journal of the American Medical Association, 2011; DOI: 10.1001/jama.2011.1246

Cite This Page:

JAMA and Archives Journals. "Study finds association between blood biomarker and risk of death." ScienceDaily. ScienceDaily, 6 September 2011. <www.sciencedaily.com/releases/2011/09/110906181653.htm>.
JAMA and Archives Journals. (2011, September 6). Study finds association between blood biomarker and risk of death. ScienceDaily. Retrieved December 21, 2014 from www.sciencedaily.com/releases/2011/09/110906181653.htm
JAMA and Archives Journals. "Study finds association between blood biomarker and risk of death." ScienceDaily. www.sciencedaily.com/releases/2011/09/110906181653.htm (accessed December 21, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Sunday, December 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Tips to Curb Holiday Carbs

The Best Tips to Curb Holiday Carbs

Buzz60 (Dec. 19, 2014) It's hard to resist those delicious but fattening carbs we all crave during the winter months, but there are some ways to stay satisfied without consuming the extra calories. Vanessa Freeman (@VanessaFreeTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Sierra Leone Bikers Spread the Message to Fight Ebola

Sierra Leone Bikers Spread the Message to Fight Ebola

AFP (Dec. 19, 2014) More than 100 motorcyclists hit the road to spread awareness messages about Ebola. Nearly 7,000 people have now died from the virus, almost all of them in west Africa, according to the World Health Organization. Video provided by AFP
Powered by NewsLook.com
Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
The Best Protein-Filled Foods to Energize You for the New Year

The Best Protein-Filled Foods to Energize You for the New Year

Buzz60 (Dec. 19, 2014) The new year is coming and nothing will energize you more for 2015 than protein-filled foods. Fitness and nutrition expert John Basedow (@JohnBasedow) gives his favorite high protein foods that will help you build muscle, lose fat and have endless energy. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins